Skip to content

To assess the effect of transversus abdominis plane (TAP) block to control pain after removal of uterus.

Evaluation of transversus abdominis plane (TAP) block in multimodal approach for postoperatve analgesia in abdominal hysterectomy done under combined spinal-epidural anaesthesia- a prospective randomised double blind study - TAP in TAH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025379
Enrollment
64
Registered
2020-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified

Interventions

Intervention1: Posterior transversus abdominis plane block: Selected patient will receive bilateral posterior TAP block with 0.375% ropivacaine after abdominal hysterectomy. Control Intervention1: Con

Sponsors

Tata Motors Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I-III 2. Total abdominal hysterectomy done via lower abdominal transverse (Pfannenstiel) incision.

Exclusion criteria

Exclusion criteria: 1. Patient refusal. 2. A history of drug allergy or local anaesthetic toxicity. 3. BMI >35kg/m2 (to limit maximum Ropivacaine dose to 3mg/kg) 4. Contraindications to regional anaesthesia (bleeding diathesis, infection at the site of block and peripheral neuropathy) 5. Change of anaesthetic technique to general anaesthesia. 6. Failure or complication in epidural catheter insertion.

Design outcomes

Primary

MeasureTime frame
Epidural morphine usedTimepoint: 24hours

Secondary

MeasureTime frame
Duration of analgesia, difference in Vas scores, PONV, Sedation and SatisfactionTimepoint: 24 hours

Countries

India

Contacts

Public ContactAshok Jadon

Tata Motors Hospital, Jamshedpur

jadona@rediffmail.com6576695676

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026